PTX 2.38% 4.1¢ prescient therapeutics limited

Among a plethora of interesting topics specific to T-cell...

  1. 7,832 Posts.
    lightbulb Created with Sketch. 3343
    Among a plethora of interesting topics specific to T-cell Lymphoma, our presentation is one of only a few based on trials in the clinic. Interestingly, PTX-100 is titled an "update".

    First day arvo sessions:-

    https://hotcopper.com.au/data/attachments/6185/6185110-7aafeab954ab692d7c66f8c59733a5ed.jpg

    Could we have the final clinical readout being presented and proposed Phase 2 trial design/s being presented?

 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.